Solutions › Pharma
In Pharma, a Missed
Regulatory Change Has Consequences.
A guidance update you didn't catch. A gap in your CMC documentation nobody found. A labeling requirement that changed while your submission was in preparation. In drug development and manufacturing, regulatory intelligence isn't a nice-to-have — it's a critical operational function. Lexim Sphere was built for exactly that responsibility.
The Cost of Missing a Regulatory Change
What happens when pharmaceutical regulatory intelligence fails
0
50+
6
15+
Regulatory Regimes
Monitored
AI Analysis Layers
on Every Document
Languages via
Relay Engine
Raw PDFs
Your Team Reads
The Challenge
We know what keeps
MedTech RA teams up at night.
Medical device regulatory affairs is one of the most complex, high-stakes disciplines in industry. The volume of regulatory activity, the consequences of missing something, and the pace of change have never been greater.
Monitoring at the Speed Regulators Move
The FDA, EMA, ICH, PMDA, and a dozen other bodies publish guidance continuously. Most teams rely on email subscriptions and manual review cycles — tools that introduce lag between a regulatory publication and the team's awareness of it. In pharma, that lag has a cost.
Solved by → Synthesis · FDA Pulse · Global pulse · Vigil
CMC Documentation Gaps
CMC — Chemistry, Manufacturing, and Controls — is one of the most documentation-intensive areas in drug development, and one of the most common sources of FDA deficiencies. As guidance evolves, CMC SOPs and dossier sections need continuous gap assessment against current requirements. Doing this manually is slow, inconsistent, and resource-intensive.
Solved by → Bridge · Cabinet · Vigil
Global Submission Inconsistency
CTD format provides a common structure, but regional variations in requirements — content, labeling, clinical data standards, manufacturing documentation — mean that a dossier prepared for FDA often needs significant rework for EMA, PMDA, and other markets. Identifying exactly what needs to change and translating the materials accurately is among the most time-consuming work in global regulatory affairs.
Solved by → Clarity · Relay · Synthesis
ICH and Guideline Lifecycle Tracking
ICH guidelines — Q, S, E, and M series — are the foundation of global pharmaceutical regulatory strategy. They evolve through step processes that can span years, and organizations need to track not just final guidelines but every consultation document, step notice, and implementation update across multiple simultaneous revisions. Manual tracking of even a handful of guidelines is a significant ongoing commitment.
Solved by → Vigil · Synthesis · Bridge
Translation Cost and Quality
Global pharmaceutical regulatory operations generate enormous translation volumes — submission dossiers, labeling, patient information leaflets, clinical documents, and correspondence with regional health authorities. Translation of regulatory and technical materials demands precision that generic translation services can't reliably deliver, and specialist pharmaceutical translation is expensive and slow.
Solved by → Relay
Cross-Functional Regulatory Impact
A single FDA guidance update can affect R&D protocols, CMC documentation, manufacturing SOPs, clinical operations, medical affairs labeling, and commercial packaging simultaneously. Regulatory affairs teams carry the burden of identifying and communicating cross-functional impact — a task that requires reading the full document and translating it for every affected function. This is where the most time is lost.
Solved by → Synthesis · Synthesis Six
The Engines
The Engines.
Built for regulatory work.
Not retrofitted for it.
While all Engines are available to pharma organizations, these four address the most specific and high-value challenges in pharmaceutical regulatory affairs.
Strategic Engine · Precision Tracking
Vigil
Every Update. In Order. In Context.
Tag any ICH guideline, FDA guidance, or EMA requirement and Docket tracks its complete lifecycle — every step notice, consultation document, final publication, and implementation update presented in chronological order. When an update arrives, trigger Bridge in one click to assess impact on your documentation immediately.
Execution Engine · Gap Analysis
Bridge
Find Every Gap. Plan Every Fix.
Run any CMC SOP, manufacturing procedure, or internal quality document against any FDA guidance, ICH guideline, or EMA requirement. Bridge produces a structured gap report — opening with a full analysis plan, then identifying every gap with specific remediation guidance. Critical for submission readiness and post-approval compliance maintenance.
Execution Engine · Translation
Relay
50+ Languages. ISO-Standard Precision.
Pharmaceutical regulatory translation is among the most exacting translation work in any industry — and among the most expensive. Relay applies ISO standards for technical and regulatory translation to any document in your Cabinet or uploaded directly, producing accurate translations in 50+ languages at a fraction of traditional cost and turnaround time. Submission dossiers, labeling, patient information leaflets, clinical documents, and regulatory correspondence — all covered.
Synthesis
Every regulatory publication.
Pre-analyzed. Cross-functionally mapped.
Lexim Synthesis monitors 15+ regulatory bodies in real time and processes every document through the Synthesis Six AI analysis framework automatically. For pharma teams, this means every FDA guidance, EMA opinion, ICH step notice, and regional regulatory publication arrives with an executive summary, cross-functional impact analysis by department, prioritized action items by function, and stakeholder FAQs — already prepared.
The Synthesis Six Impact Analysis is particularly valuable for pharmaceutical organizations where a single guidance update can touch R&D, CMC, Clinical Operations, Medical Affairs, and Commercial simultaneously. Instead of one regulatory affairs team member reading a 40-page guidance and then briefing six functions separately — Sphere does it automatically, in minutes.
FDA
ICH
+11
CDER & CBER — Drug & Biologics
Guidance documents, draft guidances, final rules, enforcement actions, and safety communications from the world's most active pharmaceutical regulator
EMA
European Medicines Agency
CHMP opinions, EMA guidelines, reflection papers, public assessment reports, and consultation documents across all therapeutic areas
International Council for Harmonisation
Q, S, E, and M series guideline updates tracked through every step — from concept paper through final implementation notice
PMDA
Pharmaceuticals & Medical Devices Agency
Japanese drug approval guidance, new drug review policies, and post-approval regulatory requirements
Additional Regulatory Bodies
Health Canada, TGA, ANVISA, NMPA, and more — 15+ regulatory regimes monitored in total across all major pharmaceutical markets
The Full Platform
Every component of Sphere
built for pharma reality.
From global regulatory monitoring to CMC gap analysis to submission translation — Lexim Sphere addresses the full breadth of pharmaceutical regulatory operations.
By Role
Find your perspective
within the platform.
Lexim Sphere serves every member of the MedTech regulatory and quality function — from the specialist doing the daily work to the executive setting the strategy.
FOR THE LEADER
VP Regulatory Affairs
Command-center visibility across your entire regulatory landscape. Know what's changing, what it means for your pipeline, and where your team's attention needs to be — without being buried in documents yourself.
FOR THE INTELLIGENCE FUNCTION
Regulatory Intelligence Analyst
The most powerful regulatory intelligence toolkit available — Synthesis, Device Lens, Periscope, and Docket working together so you can deliver deeper analysis faster than was ever previously possible.
FOR THE SPECIALIST
Regulatory Affairs Specialist
From tracking the regulations that affect your submissions to building predicate strategies and running gap analyses — Sphere handles the time-consuming work so you can focus on the decisions that require your expertise.
FOR QUALITY
QA Manager / Director
Keep your quality system current against a regulatory landscape that never stops moving. Bridge your SOPs against evolving requirements. Monitor equivalent device safety signals. Ensure your documentation is always audit-ready.
FOR THE EXECUTIVE
C-Suite
Regulatory risk is business risk. Sphere gives executive leadership the visibility to understand the regulatory landscape affecting your pipeline, your competitive position, and your market access strategy — without relying entirely on filtered reports.
Built for Pharma
Watch Bridge run on
your CMC documentation.
Book a demo tailored to pharmaceutical regulatory affairs — bring a CMC SOP or manufacturing procedure and we'll run it through Bridge against an FDA guidance or ICH guideline of your choice. See exactly where the gaps are, and what it takes to close them.